Govt Job: for M.Pharm, M.Sc as Junior Research Fellow

The Birla Institute of Technology and Science, BITS Pilani is an all-India Institute for higher education. The primary motive of BITS is to train young men and women able and eager to create and put into action such ideas, methods, techniques and information.

The Institute is a dream come true of its founder late Mr G.D.Birla – an eminent industrialist, a participant in Indian freedom struggle and a close associate of the Father of Indian Nation late Mr. Mohandas Karamchand Gandhi.

Post : Junior Research Fellow

Applications are invited from suitable candidates for the post of Junior Research Fellow to work on a research project sponsored by DST-SERB. under the supervision of Dr. Sajeli Begum, Department of Pharmacy, BITS-Pilani, Hyderabad campus.

Title of the project : Synthesis of novel coumarin-based lignans targeting pro-inflammatory cytokines for the treatment of chronic kidney diseases

Duration of the project : 3 years

Fellowship amount : Rs. 31,000/- month

Eligibility requirements :
1. M.Pharm (Medicinal Chemistry)’ M.Sc.(Organic Chemistry) with hands-on experience in synthesis and purification techniques

2. Candidates with minimum of two-years pharmaceutical industry experience will be given preference.

3. Experience in cell culture studies and animal handling would be an added advantage.

4. In addition, good oral and written communications skills are highly desirable

Interested candidates with the above mentioned qualifications can send the application along with their CV giving detailed information about their educational qualifications, research / work experience and published research papers, if any, by 13-11-2021. to the Principal Investigator, Dr. Sajeli Begum via email : sajeli@hyderabad.bits-pilani.ac.in.

Please note that only qualified and suitable candidates will be called for the interview to be held at BITS-Pilani, Hyderabad Campus in the third week of Not/. 2021 through online mode. A selected candidate may be permitted to register for the Ph.D Programme of BITS. Pilani, subject to the fulfillment of the requirements.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit